Media

Journalistin-Stimmung Medien

Media Services

Tel.: +41 58 469 92 11 

info@ivi.admin.ch

What’s new

BioCopy Holding AG e l’Istituto di virologia e di immunologia annunciano una collaborazione nel campo della peste suina africana (PDF, 103 kB, 21.04.2021)BioCopy Holding AG e l’Istituto di virologia e di immunologia (IVI) annunciano la firma di un accordo di collaborazione per la ricerca di un vaccino e lo sviluppo di nuovi metodi diagnostici contro la peste suina africana (PSA). Il virus della PSA, letale per i suini e i cinghiali, ha raggiunto la Germania orientale nel 2020 dopo anni di circolazione nell’Europa orientale.

Why SARS-CoV-2 replicates better in the upper respiratory tract (PDF, 118 kB, 27.04.2021)A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular defense mechanisms in the respiratory tract. They have shown that natural temperature differences that exist in the upper and lower respiratory tract have a profound influence on SARS-CoV-2 replication and subsequent innate immune activation in human cells. The findings can help to develop antiviral drugs and preventive measures.

SARS-CoV-2 mutations in competition (PDF, 157 kB, 21.04.2021)How dangerous are new mutations of the SARS-CoV-2 virus? An international team involving researchers from the Institute of Virology and Immunology (IVI) of the Federal Food Safety and Veterinary Office BLV and the University of Bern (Switzerland), the Centers for Disease Control and Prevention (USA), and the Friedrich-Loeffler Institute (Germany), has developed an approach that can accurately assess the transmissibility of new virus mutants.

Last modification 02.05.2021

Top of page

https://www.ivi.admin.ch/content/ivi/en/home/das-ivi/medien.html